Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.
Jang A, Lanka SM, Huang M, Casado CV, Caputo SA, Sweeney PL, Gupta K, Pocha O, Habibian N, Hawkins ME, Lieberman AD, Schwartz J, Jaeger EB, Miller PJ, Layton JL, Barata PC, Lewis BE, Ledet EM, Sartor O.
Jang A, et al. Among authors: layton jl.
Prostate. 2023 Aug;83(11):1028-1034. doi: 10.1002/pros.24544. Epub 2023 Apr 27.
Prostate. 2023.
PMID: 37113064